BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38331310)

  • 21. Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies.
    Placzek M; Friede T
    Stat Methods Med Res; 2018 Nov; 27(11):3286-3303. PubMed ID: 29298604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
    Xu J; Yu M
    Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for Designing and Evaluating Feasibility Pilot Studies.
    Teresi JA; Yu X; Stewart AL; Hays RD
    Med Care; 2022 Jan; 60(1):95-103. PubMed ID: 34812790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internal pilot studies for estimating sample size.
    Birkett MA; Day SJ
    Stat Med; 1994 Dec 15-30; 13(23-24):2455-63. PubMed ID: 7701146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian methods for pilot studies.
    Willan AR; Thabane L
    Clin Trials; 2020 Aug; 17(4):414-419. PubMed ID: 32297539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for planning pilot studies in clinical and translational research.
    Moore CG; Carter RE; Nietert PJ; Stewart PW
    Clin Transl Sci; 2011 Oct; 4(5):332-7. PubMed ID: 22029804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of calculation methods for diagnostic trials under different sample size].
    Wang Y; Hu B; Chen T; Li W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1403-5. PubMed ID: 21223674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the impact of sample size calculation and power in clinical research].
    Held U
    Praxis (Bern 1994); 2014 Oct; 103(20):1197-201. PubMed ID: 25270749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hypothesis test of feasibility for external pilot trials assessing recruitment, follow-up, and adherence rates.
    Wilson DT; Brown J; Farrin AJ; Walwyn REA
    Stat Med; 2021 Sep; 40(21):4714-4731. PubMed ID: 34121221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size calculations.
    Noordzij M; Dekker FW; Zoccali C; Jager KJ
    Nephron Clin Pract; 2011; 118(4):c319-23. PubMed ID: 21293154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roaming through the methodology. VIII. Pilot studies: sense and nonsense].
    Beurskens AJ; de Vet HC; Kant I
    Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2142-5. PubMed ID: 9856230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study.
    Teare MD; Dimairo M; Shephard N; Hayman A; Whitehead A; Walters SJ
    Trials; 2014 Jul; 15():264. PubMed ID: 24993581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Power and sample size.
    Case LD; Ambrosius WT
    Methods Mol Biol; 2007; 404():377-408. PubMed ID: 18450060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating sample size in critical care clinical trials.
    Scales DC; Rubenfeld GD
    J Crit Care; 2005 Mar; 20(1):6-11. PubMed ID: 16015511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel joint selection methods can reduce sample size for rheumatoid arthritis clinical trials with ultrasound endpoints.
    Allen JC; Thumboo J; Lye WK; Conaghan PG; Chew LC; Tan YK
    Int J Rheum Dis; 2018 Mar; 21(3):693-698. PubMed ID: 28971583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifying the design of ongoing trials without unblinding.
    Gould AL; Shih WJ
    Stat Med; 1998 Jan; 17(1):89-100. PubMed ID: 9463852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigator's introduction to statistical considerations in clinical trials.
    Winter K; Pugh SL
    Urol Oncol; 2019 May; 37(5):305-312. PubMed ID: 30926221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of internal pilots with the univariate approach to repeated measures.
    Coffey CS; Muller KE
    Stat Med; 2003 Aug; 22(15):2469-85. PubMed ID: 12872303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.